You are here

  • Home
  • Archive
  • Volume 11, Issue 4
  • Review: home-made and commercial spacers did not differ for delivery of inhaled β2 agonists in children with asthma or wheezingCommentary

Article Text

Article menu
Download PDFPDF
Treatment
Review: home-made and commercial spacers did not differ for delivery of inhaled β2 agonists in children with asthma or wheezing

https://doi.org/10.1136/ebn.11.4.105

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    C Rodriguez-Martinez

    Dr C Rodriguez-Martinez, Clínica Colsánitas, Bogota, Colombia; carlos_rodriguez2671@yahoo.com

    QUESTION

    In children with acute asthma or lower airway obstruction attacks, how do home-made and commercial spacers attached to metered-dose inhalers (MDIs) compare for delivering β2 agonists?

    REVIEW SCOPE

    Studies selected compared rapid-acting β2 agonists delivered by MDIs attached to home-made spacers with MDIs attached to commercial spacers in children and adolescents <18 years of age presenting to the emergency department (ED) with acute exacerbations of wheezing or asthma. Outcomes included hospital admission, lung function (peak expiratory flow rate [PEFR], oxygen saturation, and respiratory rate), heart rate, clinical score, intensive care unit (ICU) admission, …

    View Full Text

    Footnotes

    • Source of funding: not stated.